Abstract
Abstract: A 55-year-old female, belonging to Jehovah’s Witness community, had to undergo autologous stem transplantation (ASCT), the last ultimate option for her chemoresistant multiple myeloma. Due to her religious faith, she did not consent to transfusing blood components throughout her treatment course, which made the situation medically and ethically challenging. We, as a multidisciplinary team, formulated an individualized treatment algorithm, counseling sessions, and various special documentation to take the treatment plan forward. Risk–benefit analysis and contingency planning were crucial in her case as it was a one-of-a-kind experience. This bloodless ASCT was successful by means of thoughtful waiting, guarded management, and alternatives to blood components.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
